Towards this goal, we have used in vivo imaging methods to simultaneously image 2-NBDG and TMRE38 in a well-known Her2+/Neu GEM model of dormancy and recurrence to pinpoint metabolic signatures of breast cancer primary, regressing, dormant, and recurrent tumors. The gene discussed is ERBB2; the disease is breast cancer.